Latest news
Atara Biotherapeutics (NASDAQ:ATRA): What Could Today’s Update Reveal About Program Focus And Funding Discipline? - Kalkine MediaKalkine Media · Mon, 10 Aug 2026 08:55:00 GMTATRA DEADLINE REMINDER: Bronstein, Gewirtz & Grossman LLC Reminds - The National Law ReviewThe National Law Review · Sat, 08 Aug 2026 18:31:13 GMTAtara Biotherapeutics Inc (ATRA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 15:01:19 GMTATRA Q2'26 Earnings: EPS estimate is (0.32) USD - TradingViewTradingView · Fri, 07 Aug 2026 11:00:31 GMTATRA Q2'26 Earnings: revenue estimate is 550.00K USD - TradingViewTradingView · Mon, 03 Aug 2026 11:00:39 GMTEnterprise value to revenue forward of Atara Biotherapeutics, Inc. – NASDAQ:ATRA - TradingViewTradingView · Sat, 01 Aug 2026 04:15:31 GMTAtara Biotherapeutics Inc (ATRA) Financial Health: Profitability & Balance Sheet Analysis - TradingKeyTradingKey · Fri, 31 Jul 2026 07:00:00 GMTAtara Biotherapeutics Inc (ATRA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKeyTradingKey · Fri, 31 Jul 2026 07:00:00 GMT